JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406423200 on October 5, 2004

J. Biol. Chem., Vol. 279, Issue 52, 54248-54257, December 24, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/52/54248    most recent
M406423200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agou, F.
Right arrow Articles by Véron, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agou, F.
Right arrow Articles by Véron, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of NF-{kappa}B Activation by Peptides Targeting NF-{kappa}B Essential Modulator (NEMO) Oligomerization*

Fabrice Agou{ddagger}§, Gilles Courtois¶||, Jeanne Chiaravalli{ddagger}, Françoise Baleux**, Yves-Marie Coïc**, François Traincard{ddagger}, Alain Israël¶, and Michel Véron{ddagger}

From the {ddagger}Unité de Régulation Enzymatique des Activités Cellulaires, CNRS URA 2185, Unité de Biologie Moléculaire de l'Expression Génique, CNRS URA 2582, and **Unité de Chimie Organique, CNRS URA 2128, Institut Pasteur, 25/28 rue du Dr. Roux 75724 Paris cedex 15 France

NF-{kappa}B essential modulator/IKK-{gamma} (NEMO/IKK-{gamma}) plays a key role in the activation of the NF-{kappa}B pathway in response to proinflammatory stimuli. Previous studies suggested that the signal-dependent activation of the IKK complex involves the trimerization of NEMO. The minimal oligomerization domain of this protein consists of two coiled-coil subdomains named Coiled-coil 2 (CC2) and leucine zipper (LZ) (Agou, F., Traincard, F., Vinolo, E., Courtois, G., Yamaoka, S., Israel, A., and Veron, M. (2004) J. Biol. Chem. 279, 27861–27869). To search for drugs inhibiting NF-{kappa}B activation, we have rationally designed cell-permeable peptides corresponding to the CC2 and LZ subdomains that mimic the contact areas between NEMO subunits. The peptides were tagged with the Antennapedia/Penetratin motif and delivered to cells prior to stimulation with lipopolysaccharide. Peptide transduction was monitored by fluorescence-activated cell sorter, and their effect on lipopolysaccharide-induced NF-{kappa}B activation was quantified using an NF-{kappa}B-dependent {beta}-galactosidase assay in stably transfected pre-B 70Z/3 lymphocytes. We show that the peptides corresponding to the LZ and CC2 subdomains inhibit NF-{kappa}B activation with an IC50 in the µM range. Control peptides, including mutated CC2 and LZ peptides and a heterologous coiled-coil peptide, had no inhibitory effect. The designed peptides are able to induce cell death in human retinoblastoma Y79 cells exhibiting constitutive NF-{kappa}B activity. Our results provide the "proof of concept" for a new and promising strategy for the inhibition of NF-{kappa}B pathway activation through targeting the oligomerization state of the NEMO protein.


Received for publication, June 9, 2004 , and in revised form, October 1, 2004.

* This work was supported in by grants from "the Association pour la Recherche sur le Cancer" (ARC Grant number 5795), the Ligue Nationale contre le Cancer (équipe labelisée) (to A. I.), and the Direction de la Valorisation et des Partenariats Industriels at the Pasteur Institut. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| Present address: INSERM U532, Hôpital Saint-Louis, 75475 Paris cedex France.

§ To whom correspondence should be addressed. Tel.: 33-1-44-38-95-69; Fax: 33-1-45-68-83-99; E-mail: fagou{at}pasteur.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Palkowitsch, J. Leidner, S. Ghosh, and R. B. Marienfeld
Phosphorylation of Serine 68 in the I{kappa}B Kinase (IKK)-binding Domain of NEMO Interferes with the Structure of the IKK Complex and Tumor Necrosis Factor-{alpha}-induced NF-{kappa}B Activity
J. Biol. Chem., January 4, 2008; 283(1): 76 - 86.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
E. Wyler, M. Kaminska, Y.-M. Coic, F. Baleux, M. Veron, and F. Agou
Inhibition of NF-{kappa}B activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO
Protein Sci., September 1, 2007; 16(9): 2013 - 2022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hong, L.-C. Wang, X. Gao, Y.-L. Kuo, B. Liu, R. Merling, H.-J. Kung, H.-M. Shih, and C.-Z. Giam
Heptad Repeats Regulate Protein Phosphatase 2A Recruitment to I-{kappa}B Kinase {gamma}/NF-{kappa}B Essential Modulator and Are Targeted by Human T-lymphotropic Virus Type 1 Tax
J. Biol. Chem., April 20, 2007; 282(16): 12119 - 12126.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. B. Marienfeld, L. Palkowitsch, and S. Ghosh
Dimerization of the I{kappa}B Kinase-Binding Domain of NEMO Is Required for Tumor Necrosis Factor Alpha-Induced NF-{kappa}B Activity
Mol. Cell. Biol., December 15, 2006; 26(24): 9209 - 9219.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. C. Y. Chang, L. Zsak, Y. Feng, R. Mosseri, Q. Lu, P. Kowalski, A. Zsak, T. G. Burrage, J. G. Neilan, G. F. Kutish, et al.
Phenotype-based identification of host genes required for replication of african Swine Fever virus.
J. Virol., September 1, 2006; 80(17): 8705 - 8717.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. C. Girvan, Y. Teng, L. K. Casson, S. D. Thomas, S. Juliger, M. W. Ball, J. B. Klein, W. M. Pierce Jr., S. S. Barve, and P. J. Bates
AGRO100 inhibits activation of nuclear factor-{kappa}B (NF-{kappa}B) by forming a complex with NF-{kappa}B essential modulator (NEMO) and nucleolin.
Mol. Cancer Ther., July 1, 2006; 5(7): 1790 - 1799.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.